Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.05B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.61B |
| 3 |
Tesla
TSLA
|
+$636M |
| 4 |
TSMC
TSM
|
+$604M |
| 5 |
iShares Bitcoin Trust
IBIT
|
+$330M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.25B |
| 2 |
Apple
AAPL
|
+$1.13B |
| 3 |
Microsoft
MSFT
|
+$988M |
| 4 |
Meta Platforms (Facebook)
META
|
+$572M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$570M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 94.1% |
| 2 | Technology | 1.55% |
| 3 | Consumer Discretionary | 0.95% |
| 4 | Financials | 0.77% |
| 5 | Healthcare | 0.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1826
Simon Property Group
SPG
$69.6B
| $18.3M | ﹤0.01% |
110,201
-69,331
| -39% | -$12.1M |
|
|
BPMC
1827
PUT
DELISTED
Blueprint Medicines
BPMC
| $18.3M | ﹤0.01% |
206,600
-50,400
| -20% | -$4.92M |
|
1828
PUT
Alexandria Real Estate Equities
ARE
$9.02B
| $18.2M | ﹤0.01% |
196,600
-13,600
| -6% | -$1.33M |
|
1829
PUT
Stride
LRN
$3.55B
| $18.2M | ﹤0.01% |
143,700
+2,900
| +2% | +$367K |
|
1830
PUT
Clean Harbors
CLH
$16.5B
| $18.2M | ﹤0.01% |
92,200
+87,900
| +2,044% | +$19.2M |
|
1831
PUT
Enbridge
ENB
$109B
| $18.2M | ﹤0.01% |
410,100
-24,700
| -6% | -$1.07M |
|
1832
Viatris
VTRS
$19.4B
| $18.2M | ﹤0.01% |
2,085,684
+1,311,964
| +170% | +$13.8M |
|
1833
CALL
Dover
DOV
$27.2B
| $18.2M | ﹤0.01% |
103,400
+6,600
| +7% | +$1.27M |
|
1834
PUT
Canadian Pacific Kansas City
CP
$82.6B
| $18.2M | ﹤0.01% |
258,700
+142,000
| +122% | +$10.8M |
|
1835
PUT
ProShares Ultra QQQ
QLD
$14.2B
| $18.2M | ﹤0.01% |
408,600
-233,400
| -36% | -$12.3M |
|
1836
PUT
Quantum Computing Inc
QUBT
$1.96B
| $18.1M | ﹤0.01% |
2,264,400
+1,271,300
| +128% | +$11.2M |
|
1837
PUT
iShares US Aerospace & Defense ETF
ITA
$14B
| $18.1M | ﹤0.01% |
118,200
+31,900
| +37% | +$4.87M |
|
1838
CALL
Cincinnati Financial
CINF
$26.4B
| $18.1M | ﹤0.01% |
122,500
-14,100
| -10% | -$1.98M |
|
1839
PUT
L3Harris
LHX
$48.8B
| $18.1M | ﹤0.01% |
86,400
+15,400
| +22% | +$3.23M |
|
1840
iShares Silver Trust
SLV
$33.8B
| $18M | ﹤0.01% |
582,115
-265,793
| -31% | -$7.72M |
|
|
CNR
1841
CALL
Core Natural Resources Inc
CNR
$5.04B
| $18M | ﹤0.01% |
233,700
-167,300
| -42% | -$14.1M |
|
1842
Sea Limited
SE
$72.6B
| $18M | ﹤0.01% |
137,901
+59,628
| +76% | +$7.39M |
|
1843
Gilead Sciences
GILD
$185B
| $18M | ﹤0.01% |
160,466
-441,080
| -73% | -$45.5M |
|
1844
Yum China
YUMC
$15.3B
| $18M | ﹤0.01% |
344,987
+322,952
| +1,466% | +$15.5M |
|
1845
CALL
Lincoln National
LNC
$8.33B
| $18M | ﹤0.01% |
500,100
+78,100
| +19% | +$2.77M |
|
1846
Cboe Global Markets
CBOE
$32.8B
| $18M | ﹤0.01% |
79,343
+26,508
| +50% | +$5.5M |
|
1847
PUT
State Street
STT
$53.1B
| $17.9M | ﹤0.01% |
200,100
-186,700
| -48% | -$17.8M |
|
1848
PUT
Neurocrine Biosciences
NBIX
$15.8B
| $17.9M | ﹤0.01% |
161,400
+137,700
| +581% | +$17.4M |
|
1849
CALL
Quest Diagnostics
DGX
$26.9B
| $17.8M | ﹤0.01% |
105,400
+7,600
| +8% | +$1.25M |
|
1850
iShares MSCI Canada ETF
EWC
$6.91B
| $17.8M | ﹤0.01% |
437,412
+124,720
| +40% | +$5.12M |
|
Similar funds
Jeff Yass's Q1 2025 Portfolio in Review
As of Q1 2025, Jeff Yass held 13,842 positions worth $586B, down 12% from $663B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jeff Yass's Q1 2025 filing shows 1,775 new, 5,712 increased, 4,842 reduced and 1,482 closed positions. Its largest new stake was Brookfield Asset Management: 1,775,684 shares worth $86M. The largest sale was Invesco QQQ Trust, an estimated $1.25B.
By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, up from 93% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q1 2025 buy was Brookfield Asset Management: 1,775,684 shares worth $86M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $4.05B increase.
- Jeff Yass's biggest Q1 2025 reduction was Invesco QQQ Trust, cutting an estimated $1.25B.
- Jeff Yass fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $24M.
- Jeff Yass's ten largest holdings make up 28% of its $586B portfolio in Q1 2025.
- Jeff Yass opened 1,775 new positions and closed 1,482 in Q1 2025.
- Jeff Yass's portfolio value fell 12% quarter-over-quarter to $586B.
Based on Susquehanna International Group's 13F filing for Q1 2025, filed 14 May 2025.